Skip to main content

Status Dystonicus

  • Chapter
  • First Online:
Movement Disorder Emergencies

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Status dystonicus (SD) is a movement disorder emergency thought to be rare, although it is often underrecognized and undertreated. SD was first described in 1982 and defined as a rapidly deteriorating severe dystonia requiring urgent hospitalization. Since then, the definition and phenomenology of this entity, also known as “dystonic storm,” have been better characterized. Thus, a new definition has been proposed for SD which focuses on bulbar/respiratory dysfunction requiring hospital admission due to severe dystonia or other hyperkinetic movements, in the context of a pre-existing dystonia syndrome or in absence of any condition at baseline. This chapter provides a critical overview of SD and will specifically address the epidemiology, associated etiologies, pathophysiological mechanisms, and management of this life-threatening condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Manji H, Howard RS, Miller DH, Hirsch NP, Carr L, Bhatia K, et al. Status dystonicus: the syndrome and its management. Brain. 1998;121(Pt 2):243–52.

    Article  PubMed  Google Scholar 

  2. Jankovic J, Penn AS. Severe dystonia and myoglobinuria. Neurology. 1982;32(10):1195–7.

    Article  CAS  PubMed  Google Scholar 

  3. Marsden CD, Marion MH, Quinn N. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry. 1984;47(11):1166–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology. 1991;41(7):1141–2.

    Article  CAS  PubMed  Google Scholar 

  5. Vaamonde J, Narbona J, Weiser R, Garcia MA, Brannan T, Obeso JA. Dystonic storms: a practical management problem. Clin Neuropharmacol. 1994;17(4):344–7.

    Article  CAS  PubMed  Google Scholar 

  6. Teive HA, Munhoz RP, Souza MM, Antoniuk SA, Santos ML, Teixeira MJ, et al. Status dystonicus: study of five cases. Arq Neuropsiquiatr. 2005;63(1):26–9.

    Article  PubMed  Google Scholar 

  7. Mariotti P, Fasano A, Contarino MF, Della Marca G, Piastra M, Genovese O, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord. 2007;22(7):963–8.

    Article  PubMed  Google Scholar 

  8. Nerrant E, Gonzalez V, Milesi C, Vasques X, Ruge D, Roujeau T, et al. Deep brain stimulation treated dystonia-trajectory via status dystonicus. Mov Disord. 2018;33(7):1168–73.

    Article  PubMed  Google Scholar 

  9. Fasano A, Ricciardi L, Bentivoglio AR, Canavese C, Zorzi G, Petrovic I, et al. Status dystonicus: predictors of outcome and progression patterns of underlying disease. Mov Disord. 2012;27(6):783–8.

    Article  PubMed  Google Scholar 

  10. Sobstyl MR, Slawek JW, Zabek M. The neurosurgical treatment of patients in dystonic state – overview of the literature. Neurol Neurochir Pol. 2014;48(1):63–70.

    Article  PubMed  Google Scholar 

  11. Ruiz-Lopez M, Fasano A. Rethinking status dystonicus. Mov Disord. 2017;32(12):1667–76.

    Article  PubMed  Google Scholar 

  12. Lumsden DE, Allen NM. Rethinking status dystonicus: a welcome start to a challenging problem. Mov Disord. 2018;33(2):344.

    Article  PubMed  Google Scholar 

  13. Poston KL, Frucht SJ. Movement disorder emergencies. J Neurol. 2008;255(Suppl 4):2–13.

    Article  PubMed  Google Scholar 

  14. Baxter P. Status dystonicus: under-recognized and under-treated. Dev Med Child Neurol. 2013;55(2):99.

    Article  PubMed  Google Scholar 

  15. Garone G, Graziola F, Nicita F, Frascarelli F, Randi F, Zazza M, et al. Prestatus and status dystonicus in children and adolescents. Dev Med Child Neurol. 2020;62(6):742–9.

    Article  PubMed  Google Scholar 

  16. Allen NM, Lin JP, Lynch T, King MD. Status dystonicus: a practice guide. Dev Med Child Neurol. 2014;56(2):105–12.

    Article  PubMed  Google Scholar 

  17. Iodice A, Pisani F. Status dystonicus: management and prevention in children at high risk. Acta Biomed. 2019;90(3):207–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Lumsden DE. The spectrum of dystonia severity before status dystonicus. Dev Med Child Neurol. 2020;62(6):668.

    Article  PubMed  Google Scholar 

  19. Lumsden DE, King MD, Allen NM. Status dystonicus in childhood. Curr Opin Pediatr. 2017;29(6):674–82.

    Article  CAS  PubMed  Google Scholar 

  20. Kipps CM, Fung VS, Grattan-Smith P, de Moore GM, Morris JG. Movement disorder emergencies. Mov Disord. 2005;20(3):322–34.

    Article  PubMed  Google Scholar 

  21. Iselin-Chaves IA, Grotzsch H, Besson M, Burkhard PR, Savoldelli GL. Naloxone-responsive acute dystonia and parkinsonism following general anaesthesia. Anaesthesia. 2009;64(12):1359–62.

    Article  CAS  PubMed  Google Scholar 

  22. Dosi R, Ambaliya A, Joshi H, Patell R. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ Case Rep. 2014;2014:bcr2014204154. https://doi.org/10.1136/bcr-2014-204154.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lee MA, McGlinch EB, McGlinch MC, Capacchione JF. Malignant hyperthermia susceptibility and fitness for duty. Mil Med. 2017;182(3):e1854–e7.

    Article  PubMed  Google Scholar 

  24. Gil-Navarro S, Grandas F. Dyskinesia-hyperpyrexia syndrome: another Parkinson’s disease emergency. Mov Disord. 2010;25(15):2691–2.

    Article  PubMed  Google Scholar 

  25. Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT, et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma. 2014;31(17):1515–20.

    Article  PubMed  Google Scholar 

  26. Franzini A, Cordella R, Rizzi M, Marras CE, Messina G, Zorzi G, et al. Deep brain stimulation in critical care conditions. J Neural Transm (Vienna). 2014;121(4):391–8.

    Article  CAS  Google Scholar 

  27. Marras CE, Rizzi M, Cantonetti L, Rebessi E, De Benedictis A, Portaluri F, et al. Pallidotomy for medically refractory status dystonicus in childhood. Dev Med Child Neurol. 2014;56(7):649–56.

    Article  PubMed  Google Scholar 

  28. Svetel M, Sternic N, Pejovic S, Kostic VS. Penicillamine-induced lethal status dystonicus in a patient with Wilson’s disease. Mov Disord. 2001;16(3):568–9.

    Article  CAS  PubMed  Google Scholar 

  29. Ruiz-Lopez M, Munhoz RP, Kalia SK, Zorzi G, Nardocci N, Fasano A. Status dystonicus induced by deep brain stimulation surgery. Neurol Sci. 2020;41(3):729–30.

    Article  PubMed  Google Scholar 

  30. Oterdoom DLM, van Egmond ME, Ascencao LC, van Dijk JMC, Saryyeva A, Beudel M, et al. Reversal of status dystonicus after relocation of pallidal electrodes in DYT6 generalized dystonia. Tremor Other Hyperkinet Mov (N Y). 2018;8:530.

    Article  Google Scholar 

  31. Rohani M, Munhoz RP, Shahidi G, Parvaresh M, Miri S. Fatal status dystonicus in tardive dystonia due to depletion of deep brain stimulation’s pulse generator. Brain Stimul. 2017;10(1):160–1.

    Article  PubMed  Google Scholar 

  32. Sobstyl M, Zabek M, Kmiec T, Slawek J, Budohoski KP. Status dystonicus due to internal pulse generator depletion in a patient with primary generalized dystonia. Mov Disord. 2014;29(2):188–9.

    Article  PubMed  Google Scholar 

  33. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863–73.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, et al. Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. Mov Disord. 2016;31(4):436–57.

    Article  PubMed  Google Scholar 

  35. Meijer IA, Pearson TS. The twists of pediatric dystonia: phenomenology, classification, and genetics. Semin Pediatr Neurol. 2018;25:65–74.

    Article  PubMed  Google Scholar 

  36. Balint B, Bhatia KP. Isolated and combined dystonia syndromes – an update on new genes and their phenotypes. Eur J Neurol. 2015;22(4):610–7.

    Article  CAS  PubMed  Google Scholar 

  37. Lohmann K, Klein C. Update on the genetics of dystonia. Curr Neurol Neurosci Rep. 2017;17(3):26.

    Article  PubMed  CAS  Google Scholar 

  38. Zittel S, Ganos C, Munchau A. Fatal paroxysmal non-kinesigenic dyskinesia. Eur J Neurol. 2015;22(2):e30–1.

    Article  CAS  PubMed  Google Scholar 

  39. Sadleir LG, Paterson S, Smith KR, Redshaw N, Ranta A, Kalnins R, et al. Myoclonic occipital photosensitive epilepsy with dystonia (MOPED): a familial epilepsy syndrome. Epilepsy Res. 2015;114:98–105.

    Article  PubMed  Google Scholar 

  40. Schirinzi T, Garone G, Travaglini L, Vasco G, Galosi S, Rios L, et al. Phenomenology and clinical course of movement disorder in GNAO1 variants: results from an analytical review. Parkinsonism Relat Disord. 2019;61:19–25.

    Article  PubMed  Google Scholar 

  41. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Mohammad SS, Fung VS, Grattan-Smith P, Gill D, Pillai S, Ramanathan S, et al. Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies. Mov Disord. 2014;29(12):1539–42.

    Article  CAS  PubMed  Google Scholar 

  43. Tonduti D, Chiapparini L, Moroni I, Ardissone A, Zorzi G, Zibordi F, et al. Neurological disorders associated with striatal lesions: classification and diagnostic approach. Curr Neurol Neurosci Rep. 2016;16(6):54.

    Article  PubMed  CAS  Google Scholar 

  44. Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord. 2013;28(7):958–67.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Shakkottai VG, Batla A, Bhatia K, Dauer WT, Dresel C, Niethammer M, et al. Current opinions and areas of consensus on the role of the cerebellum in dystonia. Cerebellum. 2017;16(2):577–94.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Kojovic M, Parees I, Kassavetis P, Palomar FJ, Mir P, Teo JT, et al. Secondary and primary dystonia: pathophysiological differences. Brain. 2013;136(Pt 7):2038–49.

    Article  PubMed  Google Scholar 

  47. Termsarasab P, Frucht SJ. Dystonic storm: a practical clinical and video review. J Clin Mov Disord. 2017;4:10.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Erro R, Bhatia KP, Espay AJ, Striano P. The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies. Mov Disord. 2017;32(3):310–8.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Nakou V, Williamson K, Arichi T, Lumsden DE, Tomlin S, Kaminska M, et al. Safety and efficacy of high-dose enteral, intravenous, and transdermal clonidine for the acute management of severe intractable childhood dystonia and status dystonicus: an illustrative case-series. Eur J Paediatr Neurol. 2017;21(6):823–32.

    Article  CAS  PubMed  Google Scholar 

  50. Levi V, Zorzi G, Messina G, Romito L, Tramacere I, Dones I, et al. Deep brain stimulation versus pallidotomy for status dystonicus: a single-center case series. J Neurosurg. 2019:1–11. https://doi.org/10.3171/2019.10.JNS191691.

  51. Dalvi A, Fahn S, Ford B. Intrathecal baclofen in the treatment of dystonic storm. Mov Disord. 1998;13(3):611–2.

    Article  CAS  PubMed  Google Scholar 

  52. Kyriagis M, Grattan-Smith P, Scheinberg A, Teo C, Nakaji N, Waugh M. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health. 2004;40(5–6):322–5.

    Article  CAS  PubMed  Google Scholar 

  53. Albright AL, Barry MJ, Shafton DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001;43(10):652–7.

    Article  CAS  PubMed  Google Scholar 

  54. Ruggiero C, Meccariello G, Spennato P, Mirone G, Graziano S, Gilone M, et al. Early intraventricular baclofen therapy (IVB) for children with dystonic and dysautonomic storm. Childs Nerv Syst. 2019;35(1):15–8.

    Article  PubMed  Google Scholar 

  55. Lopez WO, Kluge Schroeder H, Santana Neville I, Jacobsen Teixeira M, Costa Barbosa D, et al. Intrathecal morphine therapy in the management of status dystonicus in neurodegeneration brain iron accumulation type 1. Pediatr Neurosurg. 2015;50(2):94–8.

    Article  PubMed  Google Scholar 

  56. Lumsden DE, Kaminska M, Ashkan K, Selway R, Lin JP. Deep brain stimulation for childhood dystonia: is ‘where’ as important as in ‘whom’? Eur J Paediatr Neurol. 2017;21(1):176–84.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Sara Breitbart, Carolina Gorodetsky, and George Ibrahim from The Hospital for Sick Children (SickKids), Toronto, ON, Canada, for having provided Fig. 10.1 and Ariane Belzile for editing references.

Funding Sources and Conflict of Interest

This work was partly funded by the Chair in Neuromodulation and Multidisciplinary care at the University of Toronto and University Health Network (A.F.)

Financial Disclosures

IAM has nothing to disclose.

AF received speaker and/or consulting honoraria and/or research support from Abbott, Boston Scientific, Brainlab, Ceregate, Ipsen, and Medtronic.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfonso Fasano .

Editor information

Editors and Affiliations

Electronic Supplementary Material

Four children with dystonic storm are shown in this video segment. The first video shows a pediatric case of status dystonic triggered by DBS surgery in a 9-year-old boy with generalized hyperkinetic movements possibly caused by an ADCY-5 mutation. Three patients with DYT-1 dystonia and dystonic storm are shown next. The first young man developed acute marked worsening of his dystonia, with severe generalized spasms involving all four limbs that required hospitalization in the intensive care unit. Despite numerous oral and intravenous medications, his dystonic spasms could not be controlled, and he eventually underwent placement of a baclofen pump (a standard procedure in the late 1990s, but not one that is used today for this entity). The second patient developed paroxysms of unremitting dystonic movements lasting hours, associated with marked sweating, fever, and elevation of CK to 5000. He was subsequently treated with deep brain stimulation of the globus pallidus interna. The third patient is afflicted with severe generalized dystonia, which temporarily worsened after a DBS stimulator became infected. A spectacular improvement in his dystonia was achieved months after bilateral DBS of the GPi (MP4 334351 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Meijer, I.A., Fasano, A. (2022). Status Dystonicus. In: Frucht, S.J. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-030-75898-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75898-1_10

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-75897-4

  • Online ISBN: 978-3-030-75898-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics